LEX Diagnostics
Zerun Mao has extensive experience in laboratory management and administration, currently serving as the Laboratory Manager and former Laboratory Coordinator at LEX Diagnostics since October 2021, where responsibilities include lab organization, safety assessments, and implementing a 5S organization system to enhance cleanliness and efficiency. Prior to this, Zerun held roles such as Lab Administrator at Novogene Europe, focusing on administrative tasks and health and safety compliance, and Legal Clerk at Avensure Ltd. Academic qualifications include a Master's Degree in Biotechnology and Enterprise from The University of Manchester and a Bachelor's Degree in Bioengineering from Sun Yat-sen University, complemented by internships related to laboratory research and a focus on innovative therapeutic proteins.
This person is not in any teams
LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, atechnology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.